ACTIVE

ORIONIS BIOSCIENCES

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result585,1 k €+2,2 %over 1 year

Revenue11,6 M €+7,9 %over 1 year

Equity4,9 M €+13,5 %over 1 year

Workforce36,3 ETP+2,3 %over 1 year

Identity

Source · BCE/KBO

ORIONIS BIOSCIENCES is a Private limited company incorporated in 2015. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Gent. It employs on average 36,3 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0635.962.088
Incorporation: 02/09/2015
Legal form: Private limited company
Registered office: Suzanne Tassierstraat 1
9052 Gent · FlandreSee on map
Contributed capital: 1 740 523,00 €
Latest accounts: 31/12/2025
Average workforce: 36,3 ETP

Activities (NACE)

72101Research and experimental development on natural sciences and engineering· main 72110Research and experimental development on biotechnology

Joint committees (2)

200
20000

Signals

ProfitableSolid equityLow riskPositive cashflowPositive EBITDA

Financials

Source · NBB, 10 filings

Trend over 10 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	11,6 M €	+7.9%	10,7 M €		–		–		–
EBITDA	1,3 M €	+3.5%	1,2 M €	+10.5%	1,1 M €	-31.5%	1,6 M €	+26.6%	1,3 M €
Operating result	523,4 k €	+20.6%	434,2 k €	+29.1%	336,3 k €	-58.2%	804,2 k €	+21.8%	660,3 k €
Net result	585,1 k €	+2.2%	572,6 k €	+125%	254,6 k €	-67.5%	783,7 k €	+52.3%	514,4 k €
Balance sheet
Equity	4,9 M €	+13.5%	4,3 M €	+15.2%	3,8 M €	+7.3%	3,5 M €	+28.7%	2,7 M €
Total assets	6,9 M €	+20.8%	5,7 M €	-2.1%	5,8 M €	-12.5%	6,7 M €	+31.8%	5 M €
Cash	717,7 k €	-12.8%	822,8 k €	-54.9%	1,8 M €	+73.2%	1,1 M €	+304%	261 k €
Debts	1,9 M €	+44.3%	1,3 M €	-34.5%	2,1 M €	-32.7%	3 M €	+31.3%	2,3 M €
Other
Workforce	36,3 ETP	+2.3%	35,5 ETP	+3.8%	34,2 ETP	-1.4%	34,7 ETP	+9.8%	31,6 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

5 active · 20 ended

Active mandates

Anthony FADELL

Director · since 17 février 2023

Active

Bihua CHEN

Director · since 05 novembre 2021

Active

Nikolai KLEY

Director · since 09 novembre 2020

Active

Griet VAN POUCKE

Director · since 27 juin 2019

Active

Steven GULLANS

Director · since 27 juin 2019

Active

Ended mandates

Nicolas KLEY

Director · since 09 novembre 2020

Ended

Nikolai KLEY

Managing director · since 09 novembre 2020 · until 27 juin 2022

Ended

Griet VAN POUCKE

Director · since 27 juin 2019 · until 27 juin 2022

Ended

Griet Vanpoucke

Director · since 27 juin 2019 · until 27 juin 2022

Ended

Other companies at this address

Suzanne Tassierstraat 1 9052 Gent

Company	CBE no.
272BIO● Active	0762.638.249
AmphiStar● Active	0771.868.491
Biotope General Partner● Active	1023.886.864
Biotope Ventures● Active	0786.781.648
Biotope Ventures II● Active	1024.242.497
EU-LIFE● Active	1038.799.823
EU-SAGE● Active	0774.834.218
I-CHALLENGE● Active	1002.343.560
LO²CUS Gent● Active	0642.937.081
Obulytix● Active	0803.351.624
Rainbow Crops● Active	1022.560.538
S-Biomedic● Active	0668.407.105
Typcal Europe● Active	1028.922.352
VIB BIO-INCUBATOR● Active	0711.986.235
VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY● Active	0456.343.923
Xpert Protein● Active	1014.642.467

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	14/07/2026	01/07/2025	10/07/2024	18/07/2023	13/07/2022	11/11/2021
General meeting	23/06/2026	26/06/2025	19/06/2024	27/06/2023	29/06/2022	29/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 10 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	23/06/2026	14/07/2026	Dutch	PDF
Abridged model	31/12/2024	26/06/2025	01/07/2025	Dutch	PDF
Abridged model	31/12/2023	19/06/2024	10/07/2024	Dutch	PDF
Abridged model	31/12/2022	27/06/2023	18/07/2023	Dutch	PDF
Abridged model	31/12/2021	29/06/2022	13/07/2022	Dutch	PDF
Abridged model	31/12/2020	29/06/2021	11/11/2021	Dutch	PDF
Abridged model	31/12/2019	26/06/2020	13/07/2020	Dutch	PDF
Abridged model	31/12/2018	25/06/2019	08/07/2019	Dutch	PDF
Micro model	31/12/2017	09/05/2018	04/06/2018	Dutch	PDF
Abridged model	31/12/2016	11/05/2017	31/05/2017	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

5 active · 20 ended

Active mandates

Anthony FADELL

Director · since 17 février 2023

Active

Bihua CHEN

Director · since 05 novembre 2021

Active

Nikolai KLEY

Director · since 09 novembre 2020

Active

Griet VAN POUCKE

Director · since 27 juin 2019

Active

Steven GULLANS

Director · since 27 juin 2019

Active

Ended mandates

Nicolas KLEY

Director · since 09 novembre 2020

Ended

Nikolai KLEY

Managing director · since 09 novembre 2020 · until 27 juin 2022

Ended

Griet VAN POUCKE

Director · since 27 juin 2019 · until 27 juin 2022

Ended

Griet Vanpoucke

Director · since 27 juin 2019 · until 27 juin 2022

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates31/07/2026
ONTSLAGEN - BENOEMINGEN
PDF
Registered office14/11/2025
MAATSCHAPPELIJKE ZETEL
PDF
Mandates08/10/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates23/03/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates11/08/2022
ONTSLAGEN - BENOEMINGEN
PDF
Other27/08/2021
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ALGEMENE VERGADERING
PDF
Mandates28/12/2020
ONTSLAGEN - BENOEMINGEN
PDF
Mandates25/07/2019
ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 2025585,1 k €↑
2024
Annual accounts 2024572,6 k €↑
2023
Annual accounts 2023254,6 k €↓
2022
Annual accounts 2022783,7 k €↑
2021
Annual accounts 2021514,4 k €↑
2020
Annual accounts 2020473,1 k €↓
2019
Annual accounts 20194,1 M €↑
2018
Annual accounts 2018-514,7 k €↑
2017
Annual accounts 2017-1,4 M €↓
2016
Annual accounts 2016-1,3 M €
02/09/2015
IncorporationPrivate limited company

ORIONIS BIOSCIENCES

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline